Orpyx Releases Latest Version of Orpyx LogR™ Cloud Software

Enhancements brings powerful new features of
real-time data

Calgary, AB, Canada, November 13, 2017  – Orpyx Medical Technologies Inc. today announced a major version release of the Orpyx LogR Cloud software.

Using feedback from customers and users, the Orpyx LogR Cloud has been enhanced with new features including:

  • Plantar-pressure analysis tools – Center of Pressure (CoP), Ground Reaction Force (GRF) and Ground Contact Time (GCT)
  • Step Count capability
  • Enhanced data visualization; including: the ability to zoom in on a Region of Interest, and the path of CoP

“This release truly demonstrates our commitment to continuously delivering increased value to all of our customers,” said Dr. Breanne Everett, CEO & co-founder of Orpyx Medical Technologies Inc. “With our product roadmap, our LogR customers can be confident that our offerings will continue to improve their research capabilities in new and exciting ways.”

About Orpyx LogR™
Orpyx LogR™ is a solution designed for the accurate, efficient, and real-time measurement of foot and plantar pressure analysis. The system is used by researchers in a variety of different applications that include footwear and orthotic design, biomechanics, sports performance, gait and balance assessments, posture research, rehabilitation, injury prevention, fall prevention, and more.

About Orpyx Medical Technologies Inc.
Orpyx Medical Technologies Inc. (“Orpyx”) is a wearable pressure sensor technology company focused on medical applications. Orpyx’s primary intention is to address the world’s growing epidemic of diabetes and its associated complications, most notably, peripheral neuropathy, which leads to lack of circulation, numbness, or loss of protective sensation, in the feet. This problem leads to the development of foot ulcers which can ultimately lead to amputation and death infection and ulcers in the feet, also known as peripheral neuropathy. Additionally, this problem affects upwards of 60% of diabetics over the course of their disease and costs the North American health care system over $16.4 billion annually.

For more information, please contact:
Chan Mean
Marketing Manager, Orpyx Medical Technologies Inc.
chan.mean@orpyx.com
+1 403 460 0216 ext. 501




Chan Mean
Chan Mean

Author